Please check your internet connection and try again.
# Oxymetazoline Nasal Spray
## Overview
Oxymetazoline is a topical decongestant that acts as an alpha-adrenergic agonist, causing vasoconstriction of nasal mucosa and reducing swelling.
## Primary Indications
* Nasal congestion associated with the common cold, allergic rhinitis, or sinusitis.
## Adult Dosing
* **Formulation:** Typically 0.05% nasal spray.
* **Dosing:** Administer 2-3 sprays into each nostril every 10-12 hours as needed.
* **Maximum Duration:** Do not use for more than 3 consecutive days to avoid rebound congestion (rhinitis medicamentosa).
## Pediatric Dosing
* **Ages 6-11 years:** Administer 2-3 sprays into each nostril every 10-12 hours as needed.
* **Under 6 years:** Safety and efficacy are not established. Consult product labeling or a pediatrician.
## Dose Adjustments
No specific dose adjustments are typically required for hepatic or renal impairment.
## Contraindications
* Hypersensitivity to oxymetazoline or any component of the formulation.
* Patients who have undergone transsphenoidal hypophysectomy or other transnasal surgery where the dura mater may have been exposed.
* Use with caution in patients with cardiovascular disease (e.g., hypertension, ischemic heart disease), diabetes, hyperthyroidism, or those receiving monoamine oxidase inhibitors (MAOIs) or within 2 weeks of discontinuing MAOIs.
## Adverse Effects
* **Common:** Nasal burning or stinging, sneezing, increased nasal discharge.
* **Less Common:** Rebound congestion (rhinitis medicamentosa) with prolonged use, headache, insomnia, dizziness, palpitations.
* **Rare:** Systemic effects such as increased blood pressure, nervousness, nausea.
## Key Drug Interactions
* **Monoamine Oxidase Inhibitors (MAOIs):** Potentiated hypertensive crisis. Avoid concurrent use and for at least 2 weeks after MAOI discontinuation.
* **Beta-blockers:** May mask reflex tachycardia.
* **Tricyclic Antidepressants (TCAs):** May potentiate hypertensive effects.
## Monitoring
* Monitor for signs of rebound congestion (worsening congestion after initial relief, especially after 3 days of continuous use).
* Assess for systemic side effects, particularly in patients with cardiovascular risk factors.
## Clinical Pearls
* Limit use to 3 consecutive days to prevent rhinitis medicamentosa.
* If congestion persists after 3 days, consider alternative therapies and consult a healthcare provider.
* Ensure proper administration technique to maximize efficacy and minimize systemic absorption.
***
*Disclaimer: This information is intended for clinical use and does not substitute for professional medical advice. Always verify current prescribing information and consult with a healthcare provider for specific patient management decisions.*
